EUVIMED · CrossrefJournal
Journal of Oncology Pharmacy Practice
ISSN 1078-1552 · SAGE Publications
Latest articles
Role of pharmacist in adverse drug reaction reporting: Enhancing antifungal safety and pharmacovigilance in cancer patients
Use of mHealth interventions in the management of chemotherapy-related adverse drug reactions
A standardized carbon footprint assessment tool for injectable chemotherapy: Development and multicenter validation
Biomarker guided therapy in triple-negative breast cancer: Clinical role of ctDNA and PD-L1
A gamified microlearning initiative to improve access to continuing education for hospital pharmacy technicians in oncology: A single-centre pilot feasibility study
First-Line Afatinib starting dose of 30 mg versus 40 mg in advanced non-small cell lung cancer with uncommon EGFR mutations: A retrospective comparative study from Vietnam
Antiemetic adherence following pharmacist counseling and chemotherapy-induced nausea and vomiting across repeated chemotherapy cycles: A retrospective cohort study
Corrigendum to “Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic”
BRAF inhibitor exposure during pregnancy: A systematic review
PembroPrep: Accelerating efficiency and minimizing patient chair time
Understanding parental perspectives on chemotherapy side effects in children with cancer at Bugando medical centre, Mwanza, Tanzania: A descriptive cross-sectional study
Response to the letter to the editor: The role of baseline hepatic function in interpreting adverse events Among patients With hepatocellular carcinoma
The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma
Additional perspectives on survival outcomes in capecitabine-treated colorectal cancer
Reply to the letter “Additional perspectives on survival outcomes in capecitabine-treated colorectal cancer”
Comparison of carboplatin dosing derived from Cockcroft–Gault creatinine clearance and race-free CKD-EPI estimated glomerular filtration rate
Implementation of a student pharmacist–led medication review program prior to metaiodobenzylguanidine (MIBG) imaging in pediatric oncology patients
Association of medication burden and potential drug–drug interactions with acute kidney injury among critically ill patients receiving anticancer therapy at a tertiary care centre
Collaboration between clinical pharmacists and physicians to manage drug-related problems in an adult hematopoietic stem cell transplantation unit
Impact of a pharmacist-led pharmacogenomic service on test capture rates in oncology: A retrospective pre-post cohort study, 2024-2026
Compatibility of closed system transfer devices with hazardous drug vials wrapped in vial protect pack shrink tack labels: Comparative evaluation between experienced pharmacists and pharmacy students
Ruxolitinib for graft-versus-host disease prophylaxis following tacrolimus toxicity: A case series
Racial disparities in treatment patterns in patients with non-small cell lung cancer before and after approval of immune checkpoint inhibitors: A population-based study
Antibody-drug conjugate use and spending in the United States, 2013–2022
Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
Drug-induced QT prolongation in oncology: A precision-medicine
Pre-ICU medication vulnerability and healthcare-access barriers associated with unplanned intensive care admission among cancer patients: A case-control study
Administration-related reactions following first-dose subcutaneous daratumumab to inform implementation of a 30-minute observation period
When hospital pharmacies procure medicines for industry-sponsored oncology trials: The hidden costs of sponsor reimbursement
Trastuzumab reloading: Regimen-specific eligibility and safety inference
EUVIMED